Regulatory Inspection History

Drug development is a highly regulated industry that is governed by the international quality standards of Good Clinical Practice (GCP) and Good Laboratory Practice (GLP). BioPharma Services has an unwavering commitment to quality and safety standards and steadfastly adheres to the principles set forth by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). 

We have a long history of regulatory inspections dating back to 2009 with inspections by the US FDA & Health Canada, European agencies (UK MHRA, French ANSM, Danish DKMA, Dutch CBG & Austrian AGES), ANVISA and the World Health Organization. We also hold GLP certification by the SCC.